Literature DB >> 21751219

Visceral obesity is associated with outcomes of total mesorectal excision for rectal adenocarcinoma.

Nikiforos Ballian1, Meghan G Lubner, Alejandro Munoz, Bruce A Harms, Charles P Heise, Eugene F Foley, Gregory D Kennedy.   

Abstract

BACKGROUND AND OBJECTIVES: General obesity, measured by the body mass index (BMI), increases the technical difficulty of total mesorectal excision (TME) but does not affect oncologic outcomes. The purpose of this study is to compare visceral and general obesity as predictors of outcomes of TME for rectal adenocarcinoma.
METHODS: Adult patients undergoing TME for rectal adenocarcinoma were retrospectively identified. Preoperative computed tomography scans were used to measure abdominal circumference (AC), visceral (VFA), and subcutaneous fat area (SFA). BMI, AC, VFA, SFA, total fat area (TFA, sum of VFA and SFA), and VFA/SFA ratio were examined for association with operative, postoperative, oncologic, and survival outcomes in a univariate analysis model.
RESULTS: Between 1999 and 2009, 113 patients met inclusion criteria. Increasing VFA and VFA/SFA ratio were associated with reduced lymph node retrieval (P = 0.03 and P = 0.009, respectively). The association between increasing VFA/SFA ratio with delayed resumption of oral intake (P = 0.05) and prolonged overall survival (P = 0.003) were also significant. Increasing BMI was associated with improved overall (P = 0.02) but not disease-free survival (P = 0.14).
CONCLUSION: Visceral obesity, measured by VFA/SFA ratio, is a better predictor of postoperative, oncologic, and survival outcomes after TME for rectal adenocarcinoma than general obesity measured by the BMI.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21751219     DOI: 10.1002/jso.22031

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  28 in total

1.  Visceral Adiposity is a Risk Factor for Poor Prognosis in Colorectal Cancer Patients Receiving Adjuvant Chemotherapy.

Authors:  Chun Seng Lee; David J Murphy; Colm McMahon; Blathnaid Nolan; Garret Cullen; Hugh Mulcahy; Kieran Sheahan; Elizabeth Barnes; David Fennelly; Elizabeth J Ryan; Glen A Doherty
Journal:  J Gastrointest Cancer       Date:  2015-09

2.  Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study).

Authors:  Bette J Caan; Jeffrey A Meyerhardt; Candyce H Kroenke; Stacey Alexeeff; Jingjie Xiao; Erin Weltzien; Elizabeth Cespedes Feliciano; Adrienne L Castillo; Charles P Quesenberry; Marilyn L Kwan; Carla M Prado
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-05-15       Impact factor: 4.254

3.  Impact of Body Composition on Surgical Outcome in Rectal Cancer Patients, a Retrospective Cohort Study.

Authors:  C Heus; N Bakker; W M Verduin; H J Doodeman; A P J Houdijk
Journal:  World J Surg       Date:  2019-05       Impact factor: 3.352

Review 4.  The Obesity Paradox in Cancer-Moving Beyond BMI.

Authors:  Shlomit Strulov Shachar; Grant R Williams
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01       Impact factor: 4.254

5.  Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma.

Authors:  Roy Mano; A Ari Hakimi; Emily C Zabor; Marta A Bury; Olivio F Donati; Christoph A Karlo; Wassim M Bazzi; Helena Furberg; Paul Russo
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

6.  Visceral obesity and colorectal cancer: are we missing the boat with BMI?

Authors:  Aaron S Rickles; James C Iannuzzi; Oleg Mironov; Andrew-Paul Deeb; Abhiram Sharma; Fergal J Fleming; John R T Monson
Journal:  J Gastrointest Surg       Date:  2012-10-23       Impact factor: 3.452

7.  Effect of BMI on outcomes in proctectomy.

Authors:  Jennifer E Hrabe; Scott K Sherman; Mary E Charlton; John W Cromwell; John C Byrn
Journal:  Dis Colon Rectum       Date:  2014-05       Impact factor: 4.585

8.  Increased perirenal fat area is not associated with adverse outcomes after laparoscopic total mesorectal excision for rectal cancer.

Authors:  Katarina Levic; Orhan Bulut; Mette Schødt; Thue Bisgaard
Journal:  Langenbecks Arch Surg       Date:  2017-11-07       Impact factor: 3.445

9.  A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment results.

Authors:  Justin C Brown; Andrea B Troxel; Bonnie Ky; Nevena Damjanov; Babette S Zemel; Michael R Rickels; Andrew D Rhim; Anil K Rustgi; Kerry S Courneya; Kathryn H Schmitz
Journal:  Contemp Clin Trials       Date:  2016-03-10       Impact factor: 2.226

10.  Computed Tomography-Based Body Composition Is Not Consistently Associated with Outcome in Older Patients with Colorectal Cancer.

Authors:  Stéphanie M L M Looijaard; Carel G M Meskers; Monique S Slee-Valentijn; Donald E Bouman; A N Machteld Wymenga; Joost M Klaase; Andrea B Maier
Journal:  Oncologist       Date:  2019-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.